JANSSEN APALUTAMIDE apalutamide 60 mg film-coated tablet bottle

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Download Laporan Penilaian Awam (PAR)
15-05-2019

Bahan aktif:

apalutamide, Quantity: 60 mg

Boleh didapati daripada:

Janssen-Cilag Pty Ltd

Borang farmaseutikal:

Tablet, film coated

Komposisi:

Excipient Ingredients: magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; hypromellose acetate succinate; croscarmellose sodium; silicified microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350; iron oxide black

Laluan pentadbiran:

Oral

Unit dalam pakej:

120 tablets

Jenis preskripsi:

(S4) Prescription Only Medicine

Tanda-tanda terapeutik:

JANSSEN APALUTAMIDE (apalutamide) is indicated for the treatment of patients with: ? metastatic castration-sensitive prostate cancer (mCSPC) or ? non-metastatic, castration-resistant prostate cancer (nmCRPC).

Ringkasan produk:

Visual Identification: Slightly yellowish green to greyish green, oblong-shaped, film-coated tablets, debossed with AR 60 on one side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Status kebenaran:

Registered

Tarikh kebenaran:

2018-07-05